For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs
Naturally advantageous grassland geography endemic to regions like Ireland or New Zealand will produce grassfed dairy protein with much higher concentrations of cysteine compared to those, for example, in California, USA
I suspect it will be some time before we get a trial with semaglutide or Tirzepatide to really understand whether a direct brain level is needed
Enter GLP-1 agonists, medications that offer new hope for women struggling with weight loss